197 related articles for article (PubMed ID: 15385951)
1. Gene therapy progress and prospects: episomally maintained self-replicating systems.
Conese M; Auriche C; Ascenzioni F
Gene Ther; 2004 Dec; 11(24):1735-41. PubMed ID: 15385951
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element.
Papapetrou EP; Ziros PG; Micheva ID; Zoumbos NC; Athanassiadou A
Gene Ther; 2006 Jan; 13(1):40-51. PubMed ID: 16094410
[TBL] [Abstract][Full Text] [Related]
3. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
4. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
5. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.
Sun TQ; Livanos E; Vos JM
Gene Ther; 1996 Dec; 3(12):1081-8. PubMed ID: 8986434
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.
Cui FD; Kishida T; Ohashi S; Asada H; Yasutomi K; Satoh E; Kubo T; Fushiki S; Imanishi J; Mazda O
Gene Ther; 2001 Oct; 8(19):1508-13. PubMed ID: 11593364
[TBL] [Abstract][Full Text] [Related]
7. Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage.
Wong SP; Argyros O; Coutelle C; Harbottle RP
Gene Ther; 2011 Jan; 18(1):82-7. PubMed ID: 20739959
[TBL] [Abstract][Full Text] [Related]
8. LCR-mediated, long-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors.
Chow CM; Athanassiadou A; Raguz S; Psiouri L; Harland L; Malik M; Aitken MA; Grosveld F; Antoniou M
Gene Ther; 2002 Mar; 9(5):327-36. PubMed ID: 11938452
[TBL] [Abstract][Full Text] [Related]
9. The functional role of S/MARs in episomal vectors as defined by the stress-induced destabilization profile of the vector sequences.
Giannakopoulos A; Stavrou EF; Zarkadis I; Zoumbos N; Thrasher AJ; Athanassiadou A
J Mol Biol; 2009 Apr; 387(5):1239-49. PubMed ID: 19248788
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.
Papapetrou EP; Zoumbos NC; Athanassiadou A
Gene Ther; 2005 Oct; 12 Suppl 1():S118-30. PubMed ID: 16231044
[TBL] [Abstract][Full Text] [Related]
11. Establishment and applications of epstein-barr virus-based episomal vectors in human embryonic stem cells.
Ren C; Zhao M; Yang X; Li D; Jiang X; Wang L; Shan W; Yang H; Zhou L; Zhou W; Zhang H
Stem Cells; 2006 May; 24(5):1338-47. PubMed ID: 16410388
[TBL] [Abstract][Full Text] [Related]
12. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene.
Wade-Martins R; White RE; Kimura H; Cook PR; James MR
Nat Biotechnol; 2000 Dec; 18(12):1311-4. PubMed ID: 11101814
[TBL] [Abstract][Full Text] [Related]
13. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
14. Scaffold/matrix attached region-based nonviral episomal vectors.
Hagedorn C; Wong SP; Harbottle R; Lipps HJ
Hum Gene Ther; 2011 Aug; 22(8):915-23. PubMed ID: 21644838
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the efficiency of transfection/expression of exogenous gene in mammalian cells.
Kishida T; Asada H; Kubo K; Sato YT; Shin-Ya M; Imanishi J; Yoshikawa K; Mazda O
J Biotechnol; 2008 Jan; 133(2):201-7. PubMed ID: 17935815
[TBL] [Abstract][Full Text] [Related]
16. Exploiting chromosomal and viral strategies: the design of safe and efficient non-viral gene transfer systems.
Lipps HJ; Bode J
Curr Opin Mol Ther; 2001 Apr; 3(2):133-41. PubMed ID: 11338925
[TBL] [Abstract][Full Text] [Related]
17. A severe de novo methylation of episomal vectors by human ES cells.
Kameda T; Smuga-Otto K; Thomson JA
Biochem Biophys Res Commun; 2006 Nov; 349(4):1269-77. PubMed ID: 16973130
[TBL] [Abstract][Full Text] [Related]
18. Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation.
Mei WH; Qian GX; Zhang XQ; Zhang P; Lu J
Haemophilia; 2006 May; 12(3):271-9. PubMed ID: 16643213
[TBL] [Abstract][Full Text] [Related]
19. MAR characteristic motifs mediate episomal vector in CHO cells.
Lin Y; Li Z; Wang T; Wang X; Wang L; Dong W; Jing C; Yang X
Gene; 2015 Apr; 559(2):137-43. PubMed ID: 25598284
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
